Document Detail


Increased uptake of actinomycin D in Ehrlich ascites tumour cells induced by daunorubicin.
MedLine Citation:
PMID:  6831629     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The influence of anthracyclines on the uptake of actinomycin D in Ehrlich ascites tumour cells was studied in vitro. The anthracycline daunorubicin significantly increased the [3H]actinomycin D uptake both in whole tumour cells and in isolated nuclei of tumour cells. On the other hand, actinomycin D increased daunorubicin uptake only to a very small degree. Experiments with other intercalating drugs did not influence [3H]actinomycin D binding, suggesting a specific interaction between actinomycin D and the anthracyclines. The mechanism behind this interference is discussed. The increased cellular uptake of actinomycin D in the presence of daunorubicin may have implications for antineoplastic combination chemotherapy.
Authors:
C Lund-Andersen; T Skovsgaard; N I Nissen
Related Documents :
14149399 - Reevaluation of assays used to show rna induction of glucose-6-phosphatase in ascites c...
20564499 - Paullinia cupana mart. var. sorbilis, guarana, increases survival of ehrlich ascites ca...
19196399 - Intervention of pyrrolidine dithiocarbamate and tetrandrine on cellular calcium overloa...
8397029 - Rous sarcoma virus genome stably integrated into mouse ascites sarcoma cells.
8075629 - Glucose strongly stimulates rate of the rrna synthesis in ehrlich ascites carcinoma cells.
6219989 - Novikoff ascites tumor cells contain n-acetyllactosaminide beta 1 leads to 3 and beta 1...
23724979 - Modifying dielectrophoretic response of nonviable yeast cells by ionic surfactant treat...
10470859 - Mannose 6-phosphate/insulin-like growth factor ii receptor mediates the growth-inhibito...
24796939 - The submerged printing of cells onto a modified surface using a continuous flow microsp...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Cancer chemotherapy and pharmacology     Volume:  10     ISSN:  0344-5704     ISO Abbreviation:  Cancer Chemother. Pharmacol.     Publication Date:  1983  
Date Detail:
Created Date:  1983-05-05     Completed Date:  1983-05-05     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7806519     Medline TA:  Cancer Chemother Pharmacol     Country:  GERMANY, WEST    
Other Details:
Languages:  eng     Pagination:  79-83     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Carcinoma, Ehrlich Tumor / drug therapy,  metabolism*
Cell Nucleus / metabolism
Cells, Cultured
Dactinomycin / metabolism*
Daunorubicin / pharmacology*
Dose-Response Relationship, Drug
Drug Interactions
Drug Therapy, Combination
Mice
Neoplasm Transplantation
Neoplasms, Experimental / metabolism
Chemical
Reg. No./Substance:
20830-81-3/Daunorubicin; 50-76-0/Dactinomycin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Antitumor activity of homo-aza-steroidal esters of [p-[bis(2-chloroethyl)amino]phenyl]acetic acid an...
Next Document:  Synthesis, biological and biochemical properties of new anthracyclines modified in the aminosugar mo...